Mr Benjamin Lamb
MB BS, MA (Cantab.), PhD, FRCS (Urol.)
I have been a Consultant Urological and Robotic Surgeon at the Department of Urology, Cambridge University Hospitals NHS Foundation Trust since 2018. I am trained in general urology and have undertaken sub-speciality training in prostate, bladder and kidney cancers. I studied medicine in Cambridge and London, before completing my specialist urological training in hospitals in London and the South of England.
I started training in robotic surgery in 2014 and have since completed fellowships in robotic surgery with the European Robotic Urological Society (ERUS) and at the Peter MacCallum Cancer Centre, Melbourne, Australia. I have performed over 350 robotic operations, giving me a high degree of experience in the application of this technology in the treatment of urological conditions.
I see patients with a range of symptoms, from lower urinary tract symptoms (LUTS), symptoms of prostatism, urinary tract infections (UTI), testicular lumps and testicular pain, blood in the urine (haematuria) or semen (haematospermia). I also see patients who may have no symptoms, for example men concerned about their PSA results, or wishing to find out about PSA tests or prostate cancer, or any other urological problem.
I tailor my approach to robotic radical prostatectomy (RARP) according to my patients’ needs and always discuss the benefits and risks of strategies intended to improve recovery (eg nerve sparing, bladder neck sparing, urethral sparing, membranous urethral length, Retzius-sparing), and those intended to maximise the chance of cancer clearance (wide excision, non-nerve sparing) when planning surgery. I believe in a shared, holistic, patient-centred approach to surgical decision making that combines my professional expertise with those things that matter most to my patients.
As well as general urological procedures and operations, I perform over 100 robotic operations per year. For my patients undergoing robotic radical prostatectomy, I perform nerve sparing in over 80% of my patients. My patients generally have excellent recovery of continence with 80% and 96% using no or one safety pad per day by six and 20 weeks, respectively. My overall rate of positive surgical margin is 21.7% (8% in pT2 and 29% in pT3 cases) compared to the national average of 26.6%.
I am on the Trial Management Group of two clinical trials - CamProbe at Cambridge University Hospitals and NeuroSafe at University College London Hospital.
Alongside my clinical practice I am an honorary clinical research fellow at Imperial College London. I have a research interest is multidisciplinary cancer teams, or MDTs, and have written and presented work on decision making, non-technical skills, and leadership in MDTs. I also enjoy teaching medical students, doctors and allied healthcare professionals on a wide range of topics from communication skills to MDT working, to urological sciences. I am course faculty on the Cambridge Emergency Urology Course, the Cambridge Cadaveric Urology Course, and the Urology Masters at Anglia Ruskin University.
Some of the principal treatments carried out by Mr Benjamin Lamb at Spire include:
• Bladder biopsy
• Bladder tumour resection (TURBT)
• Excision of epididymal cyst
• Flexible cystoscopy
• Hydrocoele repair
• Radical orchidectomy
• Rigid cystoscopy
• Robotic radical prostatectomy
Spire Cambridge Lea Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
MBBS / University of London / 2005
Bachelor of Medicine, Bachelor of Surgery
MBBS is the degree awarded to medical doctors at the completion of training
British Association of Urological Surgeons
European Association of Urology
British Medical Association
Cambridge University Hospitals NHS Foundation Trust.
Honorary Clinical Research Fellow, Imperial College London.
I enjoy spending my free time with my wife and three children, and when possible, going to the gym, or doing a spot of gardening.